Tag: MannKind Corporation


MannKind Corporation (NASDAQ: MNKD) welcomes Rule Change in Local Coverage Determination

MannKind Corporation (NASDAQ: MNKD) has appreciated the fresh labors of the Centers for Medicare and Medicaid Services (CMS) in combination with the Medicare Administration Contractors (MACs) to instigate a rule alteration in Local Coverage Determination. Rule change allows Medicare patients to select both Afrezza® and Continuous Glucose Monitors The new rule […]


MannKind Corporation (NASDAQ: MNKD) Jumps 5.6% after FDA Approves Priority Review for Tyvaso DPI NDA

MannKind Corporation (NASDAQ: MNKD) jumped 5.61% following the achievement of a significant milestone with United Therapeutics Corporation (NASDAQ: UTHR), which gained 2.8%, regarding Tyvaso DPI for pulmonary hypertension-related with interstitial lung disease and pulmonary arterial hypertension treatment. The companies announced that the US FDA had accepted a priority review for […]